Development and Validation of a Model to Predict Tyrosine Kinase Inhibitor-Sensitive EGFR Mutations of Non-Small Cell Lung Cancer Based on Multi-Institutional Data
Thoracic Cancer - Australia
doi 10.1111/1759-7714.12881
Full Text
Open PDFAbstract
Available in full text
Date
October 3, 2018
Authors
Publisher
Wiley